The Role of Unobtrusive Home-Based Continuous Sensing in the Management of Postacute Sequelae of SARS CoV-2
Amid the COVID-19 pandemic, it has been reported that greater than 35% of patients with confirmed or suspected COVID-19 develop postacute sequelae of SARS CoV-2 (PASC). PASC is still a disease for which preliminary medical data are being collected—mostly measurements collected during hosp...
Main Authors: | Benjamin Harris Peterson Corman, Sritha Rajupet, Fan Ye, Elinor Randi Schoenfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-01-01
|
Series: | Journal of Medical Internet Research |
Online Access: | https://www.jmir.org/2022/1/e32713 |
Similar Items
-
Postacute Sequelae of SARS-CoV-2 in University Setting
by: Megan Landry, et al.
Published: (2023-03-01) -
Postacute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked
by: Antonios A. Koutalos, et al.
Published: (2022-08-01) -
Postacute sequelae of SARS-CoV-2 (PASC) in nursing home residents: A case–control study
by: Sophie Clark, et al.
Published: (2022-07-01) -
Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection
by: Hyung J. Chun, et al.
Published: (2021-07-01) -
Cardiac postacute sequelae symptoms of SARS-CoV-2 in community-dwelling adults: cross-sectional study
by: Patricia M Davidson, et al.
Published: (2022-08-01)